| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -178,410 | 100% | $41.33 | -$7,374,474 |
| Net | -9 | -178,410 | -100% | -$7,374,474 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| EMIL D. KAKKIS | President & CEO, Director | $118,730,558 | -$4,153,571 | -3.4% | 28 Feb 2025 |
| Thomas Richard Kassberg | Cbo & Evp | $11,362,212 | -$253,779 | -2.2% | 01 Mar 2025 |
| Dennis Karl Huang | Officer | $4,918,246 | 01 Mar 2025 | ||
| John Richard Pinion | Officer | $4,653,730 | -$607,882 | -12% | 01 Mar 2025 |
| Erik Harris | EVP & Chief Commercial Officer | $3,698,696 | -$635,836 | -15% | 01 Mar 2025 |
| Howard Horn | Chief Financial Officer | $3,461,411 | -$434,453 | -11% | 10 Dec 2025 |
| Eric Crombez | EVP and Chief Medical Officer | $2,806,837 | -$405,486 | -13% | 21 Apr 2025 |
| Karah Parschauer | EVP and Chief Legal Officer | $2,283,857 | -$745,407 | -25% | 12 Sep 2025 |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | $1,734,471 | -$48,137 | -2.7% | 29 Dec 2025 |
| William Aliski | Director | $1,623,405 | 24 Jun 2021 | ||
| Mardi Dier | CFO & Executive Vice President | $1,400,595 | 14 Oct 2022 | ||
| DANIEL G. WELCH | Director | $1,241,566 | 15 May 2025 | ||
| MICHAEL NARACHI | Director | $1,241,566 | 15 May 2025 | ||
| Deborah Dunsire | Director | $1,170,353 | 15 May 2025 | ||
| Matthew K. Fust | Director | $985,391 | 15 May 2025 | ||
| SHEHNAAZ SULIMAN | Director | $985,201 | 15 May 2025 | ||
| Camille L. Bedrosian | EVP and Chief Medical Officer | $981,120 | 01 Mar 2023 | ||
| Amrit Ray | Director | $887,402 | 15 May 2025 | ||
| (Corsee) Sanders Corazon | Director | $573,712 | -$89,923 | -14% | 20 Jun 2025 |
| Lars Ekman | Director | $372,645 | 24 Jun 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|